World News: 11:05 GMT Thursday 6th December 2018. [Research and Markets via Globe Newswire via SPi World News]
Dublin, Dec. 06, 2018 (GLOBE NEWSWIRE) -- The report has been added to offering.
The basal cell carcinoma therapeutics market will register a CAGR of around 6% by 2022.
The advancements in the field of oncology research is expected to help the market grow during the forecast period. The key players in the market are constantly developing medicines for various cancer indications.
With the presence of a considerable number of companies, this market appears to be fragmented. This market research report will help clients identify new growth opportunities. Some of the established pharmaceutical companies and various government organizations are investing profoundly in the R&D of novel therapies, which is currently dominated by biologic molecules due to their high effectiveness.
For more information about this report visit
Research and Markets also offers services providing focused, comprehensive and tailored research.
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Skin Cancer Drugs
Globe Newswire: 11:05 GMT Thursday 6th December 2018
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.